FDA Notes 2 Byetta Deaths
Date: Tuesday, August 19 @ 12:33:06 CDT
Topic: Scienze
By Miranda Hitti Aug. 18, 2008 -- The FDA today said it plans to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two more reports of deaths and four other hospitalizations in Byetta...
FDA Says Diabetes Drug Byetta Caused Deaths August 19th, 2008 | by admin |
Washington (ChatterShmatter) - Shares in drug companies Eli Lilly & Co. and Amylin Pharmaceuticals Inc. have fallen since the FDA released a statement linking their diabetes drug Byetta to numerous deaths in patients. The drug has been approved in the US since 2005 and now appears to increase a person’s risk of developing an inflamed pancreas, a condition which can be fatal. It is a drug injected twice a day, and assists type 2 diabetes patients to lower their blood sugar. Amylin is based in SanDiego and its shares are down 13 percent, to $28.86, while Eli Lilly shares fell 1.7 percent. For drug maker Amylin, the majority of their earnings over the first half of 2008 came from sales of Byetta, bad news because the FDA is planning to add a tougher warning to the label. The FDA noted a number of cases in which Byetta users were admitted to hospital with acute pancreatitis and bleeding resulting in two of them dying.
Source: Chatter Shmatter
|
|